UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549



                                   FORM 10-QSB


(x) QUARTERLY REPORT UNDER SECTION 13 OR 15 OF THE SECURITIES
     EXCHANGE ACT OF 1934


For the quarterly period ended September 30, 2002
                               ------------------


Commission file number   0-30351
                         -------


     TRUE HEALTH,  INC. (Exact name of small business issuer as specified in its
charter)


Utah                                                            75-2263732
(State or other jurisdiction
of incorporation or                           (IRS Employer Identification No.)
organization)

    5 Tansey Circle, Mesquite, Texas 75149
(Address of principal executive offices)

    (972) 644-1200
(Issuer's  telephone number)
     Securities  registered  pursuant to Section 12(g) of the Act: Common Stock,
Par Value $0.01 Per Share

     Indicate by check mark whether the Registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. Yes X No______

    As of September 30, 2002, there were outstanding 6,545,548 shares of
True Health, Inc., Common Stock, par value $.01.

    Transitional Small Business Disclosure Format (Check one):Yes    No     x
                                                              ------ --------
<PAGE>






                                   FORM 10-QSB

                                TRUE HEALTH, INC.
                              Index to Form 10-QSB


                                     PART I



FINANCIAL INFORMATION (UNAUDITED)

ITEM 1.  FINANCIAL STATEMENTS

Balance Sheets as of September 30, 2002 and December 31, 2001

Statements of Income (Loss) for the Nine Months
   Ended September 30, 2002 and 2001

Statements of Income (Loss) for the Quarters Ended September 30, 2002 and 2001

Statements of Cash flows for the Nine Months Ended September 30, 2002 and 2001

Statements of Cash flows for the Quarters Ended September 30, 2002 and 2001

Notes to Financial Statements


ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS


                                     PART II
OTHER INFORMATION
Item 1

SIGNATURES



<PAGE>


                                TRUE HEALTH, INC
                                 Balance Sheets
              September 30, 2002 (unaudited) and December 31, 2001

<TABLE>
<CAPTION>

                                                                September 30,            December 31,
                                                                2002                    2001

<S>                                                                <C>                     <C>
ASSETS
  Current assets:
    Cash                                                                 $207                    $478
    Accounts receivable, trade                                            209                     120
    Inventory                                                          10,499                  10,523
                                                                   ----------              ----------
    Total current assets                                               10,915                  11,121
                                                                   ----------              ----------

  Office and computer equipment, net
    of accumulated depreciation of
    $1,952 and $1,766                                                     183                     369
                                                                   ----------              ----------
    Total assets                                                      $11,098                 $11,490
                                                                   ==========              ==========

LIABILITIES
  Current liabilities:
    Accounts payable and accrued expenses                             $44,369                 $28,560
    Due to related parties                                             82,876                  84,463
                                                                   ----------              ----------
    Total current liabilities                                         127,245                 113,023
                                                                   ----------              ----------
    Total liabilities                                                 127,244                 113,023
                                                                   ----------              ----------

  Commitments and contingencies                                             -                       -

STOCKHOLDERS' DEFICIT
  Common stock, $.01 par value,
    100,000,000 shares authorized,
    6,545,548 and 6,071,048 shares
    issued and outstanding                                             65,466                  60,710
  Capital in excess of par value                                      831,509                 824,009
  Accumulated deficit                                              (1,013,111)               (986,252)
                                                                    ---------               ---------
    Total stockholders' deficit                                      (116,147)               (101,533)
                                                                    ---------               ---------
    Total liabilities and stockholders'
      Deficit                                                         $11,098                 $11,490
                                                                    =========               =========

</TABLE>




The accompanying notes are an integral part of these statements.
<PAGE>


                                TRUE HEALTH, INC.
                  Statements of Loss For The Nine Months Ended
                           September 30, 2002 and 2001
                                   (Unaudited)
<TABLE>
<CAPTION>

                                                                  2001                  2002
                                                                  (Unaudited)             (Unaudited)
<S>                                                                 <C>                     <C>
Sales                                                                 $21,004                 $24,397
Cost of sales                                                           4,181                   4,521
                                                                    ---------               ---------
  Gross profit                                                         16,823                  19,876

Selling, general and administrative
  Expenses                                                             43,937                  31,796
                                                                    ---------               ---------
  Loss from operations                                                (27,114)                (11,920)

Other income                                                              255                     262
                                                                    ---------               ---------
  Income (loss) before taxes on income                                (26,859)                (11,658)

Provision for taxes on income                                               -                       -
                                                                    ---------               ---------
  Net income (loss)                                                  ($26,859)               ($11,658)
                                                                    =========               =========

Income (loss) per common share, basic                                 (0.00)                  (0.00)
                                                                    =========               =========
Weighted average number of shares
  Outstanding                                                       6,362,968               6,071,048
                                                                    =========               =========


</TABLE>












The accompanying notes are an integral part of these statements.
<PAGE>


                                TRUE HEALTH, INC.
                    Statements of Loss For The Quarters Ended
                           September 30, 2002 and 2001
                                   (Unaudited)
<TABLE>
<CAPTION>

                                                                  2001                  2002
                                                                  (Unaudited)             (Unaudited)

<S>                                                                 <C>                     <C>
Sales                                                                  $8,319                  $6,660
Cost of sales                                                           1,547                   1,179
                                                                    ---------               ---------
  Gross profit                                                          6,772                   5,481

Selling, general and administrative
  Expenses                                                             13,186                   9,080
                                                                    ---------               ---------
  Loss from operations                                                 (6,414)                 (3,599)

Other income                                                              255                     262
                                                                    ---------               ---------
  Income (loss) before taxes on income                                 (6,159)                 (3,337)

Provision for taxes on income                                               -                       -
                                                                    ---------               ---------
  Net income (loss)                                                   ($6,159)                ($3,337)
                                                                    =========               =========

Income (loss) per common share, basic                                  (0.00)                 (0.00)
                                                                    =========               =========
Weighted average number of shares
  Outstanding                                                       6,502,505               6,071,048
                                                                    =========               =========


</TABLE>










The accompanying notes are an integral part of these statements.


<PAGE>


                                TRUE HEALTH, INC.
               Statements of Cash Flows For The Nine Months Ended
                           September 30, 2002 and 2001
                                   (Unaudited)
<TABLE>
<CAPTION>

                                                                  2001                  2002
                                                                  (Unaudited)             (Unaudited)
Cash flows from operating activities:
<S>                                                                 <C>                     <C>
  Net income (loss)                                                  ($26,859)               ($11,658)
  Adjustments to reconcile net income
    to cash provided (used) by
    operating activities:
      Depreciation                                                        186                     185
      Changes in operating assets and
        liabilities:
          Accounts receivable, trade                                      (89)                      -
          Inventory                                                        24                  (2,456)
          Accounts payable and accrued
            Expenses                                                   15,809                   7,358
          Stock issued for services                                    12,500                       -
          Return and cancellation of
            stock issued in prior years
            for services                                                 (255)                      -
                                                                    ---------               ---------
  Cash flows from operating activities                                  1,316                  (6,571)
                                                                    ---------               ---------

Cash flows from investing activities                                        -                       -
                                                                    ---------               ---------

Cash flows from financing activities:
  Stock issued for services                                            12,500                       -
  Less, Amount recognized as operating
    Expenses                                                          (12,500)                      -
  Advances from related parties                                        (1,587)                  5,559
                                                                    ---------               ---------
  Cash flows from financing activities                                 (1,587)                  5,559
                                                                    ---------               ---------
Net increase (decrease) in cash and
  cash equivalents                                                       (271)                 (1,012)

Cash and cash equivalents:
  Beginning of period                                                     478                   1,280
                                                                    ---------               ---------
  End of period                                                          $207                    $268
                                                                    =========               =========
Supplemental cash flow disclosures:
  Cash paid for interest                                                    -                       -
  Noncash investing and financing activities:
    Stock issued for services                                         $12,500                       -


</TABLE>



The accompanying notes are an integral part of these statements.


<PAGE>


                                TRUE HEALTH, INC.
                 Statements of Cash Flows For The Quarters Ended
                           September 30, 2002 and 2001
                                   (Unaudited)
<TABLE>
<CAPTION>

                                                                  2001                  2002
                                                                  (Unaudited)             (Unaudited)
Cash flows from operating activities:
<S>                                                                 <C>                     <C>
  Net income (loss)                                                   ($6,159)                ($3,337)
  Adjustments to reconcile net income
    to cash provided (used) by
    operating activities:
      Depreciation                                                         62                      61
      Changes in operating assets and
        liabilities:
          Accounts receivable, trade                                        -                     294
          Inventory                                                       347                    (532)
          Accounts payable and accrued
            Expenses                                                    5,258                   1,096
          Stock issued for services                                     2,500                       -
          Return and cancellation of
            stock issued in prior years
            for services                                                 (255)                      -
                                                                    ---------               ---------
  Cash flows from operating activities                                  1,753                  (1,354)
                                                                    ---------               ---------

Cash flows from investing activities                                        -                       -
                                                                    ---------               ---------

Cash flows from financing activities:
  Stock issued for services                                             2,500                       -
  Less, Amount recognized as operating
    Expenses                                                           (2,500)                      -
  Advances from related parties                                        (1,800)                    750
                                                                    ---------               ---------
  Cash flows from financing activities                                 (1,800)                    750
                                                                    ---------               ---------
Net increase (decrease) in cash and
  cash equivalents                                                        (47)                   (604)

Cash and cash equivalents:
  Beginning of period                                                     254                     872
                                                                    ---------               ---------
  End of period                                                          $207                    $268
                                                                    =========               =========
Supplemental cash flow disclosures:
  Cash paid for interest                                                    -                       -
  Noncash investing and financing activities:
    Stock issued for services                                          $2,500                       -


</TABLE>



The accompanying notes are an integral part of these statements.


<PAGE>


                                TRUE HEALTH, INC.
                     NOTES TO UNAUDITED FINANCIAL STATEMENTS

Note 1 - Basis of presentation:
The financial statements include the accounts of True Health, Inc. The Balance
Sheets as of September 30, 2002 and December 31, 2001, the Statements of Loss
for the nine months quarters ended September 30, 2002 and 2001, and the
Statements of Cash Flows for the nine months and quarters ended September 30,
2002 and 2001 have been prepared by the Company without audit. In the opinion of
management, these financial statements include all adjustments necessary to
present fairly the financial position, results of operations and cash flows as
of September 30, 2002 and 2001 and for the nine months and quarters then ended.
All adjustments made have been of a normal recurring nature. Certain information
and footnote disclosures normally included in the financial statements prepared
in accordance with U.S. generally accepted accounting principles have been
condensed or omitted. The Company believes that the disclosures included are
adequate and provide a fair presentation of interim period results. Interim
financial statements are not necessarily indicative of financial position of
operating results for an entire year. It is suggested that these interim
financial statements be read in conjunction with the audited financial
statements and the notes thereto included in the Company's Form 10-KSB for the
year ended December 31, 2001 filed with the United States Securities and
Exchange Commission (SEC) on or about April 15, 2002.

Note 2 - The Company, nature of operations:
True Health, Inc. (the Company) is a Utah corporation engaged in the marketing
of nutrition supplement/meal replacement products under the brand name True
Health. Substantially all of its revenues are derived from these products. The
products are distributed from the Company's facilities in Texas to customers
throughout the world. The accompanying financial statements have been prepared
on the basis of U.S. generally accepted accounting principles.

Note 3 - Agreement with Burkshire:
In March, 2002, the Company issued 400,000 shares to stock to Burkshire Capital
Group, a financial consulting firm, for services in connection with management,
marketing, consulting, strategic planning, corporate organization and structure,
expansion of services, acquisitions and business opportunities, and arranging
equity financing. The consultant was expected to assist the Company in making
private placements of its stock. The services were valued at $10,000, or $0.025
per share. Burkshire's efforts were unsuccessful. Therefore, amount of $10,000,
which was originally recorded as prepaid expenses during the quarter ended March
31, 2002, was charged to expense during the quarter ended June 30, 2002.

Note 4 - Going concern:
The Company has experienced losses in eight of the previous ten years. Losses
amount to more than $1,000,000 on a cumulative basis. At September 30, 2002,
current liabilities exceeded current assets by approximately $116,000, resulting
in a working capital deficiency; there is also a capital deficit of the same
approximate amount. Management is currently investigating alternative marketing
strategies, methods, and markets, and is seeking additional outside financing
and/or equity investors, but there is no assurance that management's efforts in
this regard will be successful. Moreover, substantially all revenues are derived
from a single product or line of products, creating a concentration of business;
should the Company be unable for any reason to continue sales of the products,
it would have a severe impact on the Company's business. All of the above
factors create substantial doubt about the Company's ability to continue as a
going concern.


<PAGE>




ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS

RESULTS OF OPERATIONS
The company had year-to-date sales of $21,004 for the nine months ending
September 30, 2002, versus $24,397 for the same period of 2001. During the
quarter ended September 30, 2002, sales were down $1,659 from the preceding
year. The decrease in sales resulted primarily from Company management's focus
on raise additional equity capital and in negotiating agreements with a
financial consulting firm (see below). Year-to-date selling, general, and
administrative expenses increased to $43,937 from $31,796, primarily due to
consulting fees paid to Burkshire Capital Group. Year-to-date net loss increased
to $27,114 from $11,920, and the loss for the quarter ended September 30, 2002
increased to $6,414 from $3,599.

The Company had total assets of $11,098 at June 30, 2002, compared to $11,490 at
December 31, 2001, an insignificant change.

In October 2001, the Company completed a reverse stock split whereby each ten
(10) shares of the Corporation's $0.01 par value common stock outstanding were
converted into one (1) share of the Corporation's $0.01 par value common stock.
Concurrently therewith, the Company's ticker symbol changed from TEHI to TRHH.

In March, 2002, the Company issued 400,000 shares to stock to Burkshire Capital
Group, a financial consulting firm, for services in connection with management,
marketing, consulting, strategic planning, corporate organization and structure,
expansion of services, acquisitions and business opportunities, and arranging
equity financing. The consultant was expected to assist the Company in making
private placements of its stock. The services were valued at $10,000, or $0.025
per share. Burkshire's efforts were unsuccessful. Therefore, amount of $10,000,
which was originally recorded as prepaid expenses during the quarter ended March
31, 2002, was charged to expense during the quarter ended June 30, 2002.

During the quarter ended September 30, 2002 shareholders returned 25,500 shares
of common stock which had been issued for services rendered. The shares were
canceled. The transaction was recorded at the par value of the shares issued, or
$ 255, and was credited to other income.

Also during the third quarter the company issued common stock to one of the
former directors of the company for services rendered. A total of 100,000 shares
valued at $.025 per share, or $2,500, were issued, and charged to expense.

Part II - Other Information

ITEM 1 - Legal Proceedings:

None.

ITEM 2 - Changes in Securities:

In March, 2002, the Company issued 400,000 shares to stock to Burkshire Capital
Group, a financial consulting firm, for services in connection with management,
marketing, consulting, strategic planning, corporate organization and structure,
expansion of services, acquisitions and business opportunities, and arranging
equity financing. The consultant was expected to assist the Company in making
private placements of its stock. The services were valued at $10,000, or $0.025
per share. Burkshire's efforts were unsuccessful. Therefore, amount of $10,000,
which was originally recorded as prepaid expenses during the quarter ended March
31, 2002, was charged to expense during the quarter ended June 30, 2002.

During the quarter ended September 30, 2002 shareholders returned 25,500 shares
of common stock which had been issued for services rendered. The shares were
canceled. The transaction was recorded at the par value of the shares issued, 0r
$ 255, and was credited to other income.

Also during the third quarter the company issued common stock to one of the
former directors of the company for services rendered. A total of 100,000 shares
valued at $.025 per share, or $2,500, were issued, and charged to expense.

ITEM 3 - Defaults Upon Senior Securities:

None.

ITEM 4 - Submission of Matters to a Vote of Security Holders:

The Company had an annual shareholders meeting on August 1, 2002. A slate of
officers was elected for the next year and a reverse stock split was approved.

ITEM 5 - Other Information:

 This form 10-QSB includes or may include certain forward-looking statements
concerning the Company's financial position, business strategy, budgets,
projected costs and plans and objectives of management for future operations as
well as other statements including words such as "anticipate," "believe,"
"plan," "estimate," "expect," "intend," and other similar expressions. Although
the Company believes its expectations reflected in such forward-looking
statements are based on reasonable assumptions, readers are cautioned that no
assurance can be given that such expectations will prove correct and that actual
results and developments may differ materially from those conveyed in such
forward-looking statements. Important factors that could cause actual results to
differ materially from the expectations reflected in the forward-looking
statements in the Form 10-SB include, among others, the pace of technological
change, the Company's ability to manage growth, general business and economic
conditions in the Company's operating regions, and competitive and other
factors, all as more fully described in the Company's Report on Form 10-SB for
the period ended December 31, 2001, under Management's Discussion and Analysis
of Financial Condition and Results of Operations. "Assumptions Underlying
Certain Forward-Looking Statements and Factors that May Affect Future Results"
and elsewhere from time to time in the Company's other SEC reports. Such
forward-looking statements speak only as of the date on which they are made and
the Company does not undertake any obligation to update any forward-looking
statement to reflect events or circumstances after the date of this Form 10-QSB.
If the Company does update or correct one or more forward-looking statements,
investors and others should not conclude that the Company would make additional
updates or corrections with respect thereto or with respect to other
forward-looking statements. Actual results may vary materially.

ITEM 6.  Exhibits And Reports On Form 8-K:

None.

    SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange
Act of 1934, the Registrant has duly caused this report to be signed on its
behalf by the undersigned, thereunto duly authorized.

True Health, Inc.
-----------------
(Registrant)


Date:  November 19,200s

By:  /s/ Richard M. Stokley, President
          (Signature)
Richard M. Stokley,
President



<PAGE>


                                  CERTIFICATION

I, Richard M. Stokley, certify that:

1.   I have reviewed this quarterly report on Form 10-Q of True Health, Inc.,

a.   Based on my knowledge, this quarterly report does not contain any untrue
     statement of a material fact or omit to state a material fact necessary to
     make the statements made, in light of the circumstances under which such
     statements were made, not misleading with respect to the period covered by
     this quarterly report; and

2.   Based on my knowledge, the financial statements, and other financial
     information included in this quarterly report, fairly present in all
     material respects the financial condition, results of operations and cash
     flows of the registrant as of, and for, the periods presented in this
     quarterly report.

3.   I am responsible for the establishing and maintaining disclosure controls
     and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the
     registrant and have:

a.   designed such disclosure controls and procedures to ensure that material
     information relating to the registrant is made known to me, particularly
     during the period in which this quarterly report is being prepared;

b.   evaluated the effectiveness of the registrant's disclosure controls and
     procedures as of a date within 90 days prior to the filing date of this
     quarterly report (the "Evaluation Date"); and

c.   presented in this quarterly report our conclusions about the effectiveness
     of the disclosure controls and procedures based on our evaluation as of the
     Evaluation Date;

4.       I have disclosed, based on my most recent evaluation, to the
         registrant's auditors and the audit committee of registrant's board of
         directors (or persons performing equivalent function):

a.   all significant deficiencies in the design or operation of internal
     controls which could adversely affect the registrant's ability to record,
     process, summarize and report financial data and have identified for the
     registrant's auditors any material weaknesses in internal controls; and

b.   any fraud, whether or not material, that involves management or other
     employees who have a significant role in the registrant's internal
     controls; and

5.   I have indicated in this quarterly report whether or not there were
     significant changes in internal controls or in factors that could
     significantly affect internal controls subsequent to the date of my most
     recent evaluation, including any corrective actions with regard to
     significant deficiencies and material weaknesses.


         Date:  November 19, 2002




         By:   /s/ Richard M. Stokley
         (signature)
         Richard M. Stokley
         President